文献速递神经肿瘤

WHO I级脑膜瘤次全切除后辅助放疗的倾向评分匹配分析

Effect of adjuvant radiotherapy after subtotal resection for WHO grade I meningioma: a propensity score matching analysis of the Brain Tumor Registry of Japan.
PubMed 文献 · J Neurooncol · 2021-05-17

基于日本脑肿瘤登记库回顾性分析406例WHO I级脑膜瘤次全切除患者,18.0%接受辅助放疗。多因素Cox回归显示未放疗与更短无进展生存相关(HR 2.52,95%CI 1.33-5.42,p=0.004),倾向评分匹配后放疗组PFS显著更长(HR 3.46,95%CI 1.53-8.59,p=0.003),但获益仅见于颅底脑膜瘤。

要点

  • WHO I级脑膜瘤次全切除后辅助放疗可改善肿瘤控制。
  • 辅助放疗的获益可能仅限于颅底脑膜瘤,非颅底者未见显著获益。
  • 倾向评分匹配后放疗组PFS显著优于未放疗组。

核心结论

  • 辅助放疗改善WHO I级脑膜瘤次全切除后的肿瘤控制,但获益可能仅限于颅底脑膜瘤。

研究设计与样本

  • 回顾性分析日本脑肿瘤登记库2001-2008年7341例颅内脑膜瘤中406例WHO I级次全切除患者。
  • 采用倾向评分匹配生成各73例的放疗组与未放疗组。

主要发现

  • 73例(18.0%)接受辅助放疗,中位随访6.0年(四分位距2.7-7.7年)期间90例(22.2%)复发。
  • 全队列多因素Cox回归显示未放疗与更短PFS显著相关(HR 2.52,95%CI 1.33-5.42,p=0.004)。
  • 颅底脑膜瘤放疗效果显著(p=0.003),非颅底者不显著(p=0.69)。
  • 倾向评分匹配后放疗组PFS显著更长(HR 3.46,95%CI 1.53-8.59,p=0.003)。

临床怎么用

  • WHO I级脑膜瘤次全切除后,尤其颅底部位,可考虑辅助放疗以改善肿瘤控制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to improve the understanding of the role of adjuvant radiotherapy (AR) after subtotal resection (STR) of World Health Organization (WHO) grade I meningiomas. METHODS: We retrospectively reviewed the Brain Tumor Registry of Japan database. Among 7341 patients diagnosed with intracranial meningioma during 2001-2008, we identified 406 patients with WHO grade I meningioma treated with STR as initial treatment. Data on progression-free survival (PFS) were assessed for their relevance to clinical factors including age, sex, tumor location and size, presence of preoperative symptoms, and AR. RESULTS: AR was administered for 73 patients (18.0%). Regrowth occurred in 90 cases (22.2%) during the median follow-up period of 6.0 years (interquartile range, 2.7-7.7 years). Multivariate Cox regression analysis of the entire cohort showed that no AR was associated with significantly shorter PFS (hazard ratio [HR] 2.52, 95% confidence interval [CI] 1.33-5.42, p = 0.004). The therapeutic effect of AR was confirmed for skull base, but not non-skull base, meningiomas (p = 0.003 and 0.69, respectively). Propensity score matching analysis balanced the influence of confounding factors to generate AR+ and AR- cohorts of 73 patients each. PFS was significantly longer in the AR+ cohort than in the AR- cohort (HR 3.46, 95% CI 1.53-8.59, p = 0.003). Subgroup analysis demonstrated the favorable effect of AR only for skull base meningiomas. CONCLUSIONS: Our study revealed that AR improves tumor control after STR in WHO grade I meningiomas. However, this beneficial effect might be limited to skull base meningiomas.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Oya S, Ikawa F, Ichihara N, et al. Effect of adjuvant radiotherapy after subtotal resection for WHO grade I meningioma: a propensity score matching analysis of the Brain Tumor Registry of Japan. J Neurooncol. 2021. PMID: 34002302. doi:10.1007/s11060-021-03775-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。